Navigation Links
Complete Agenda Announced for 11th Annual Patient Adherence Forum

BOSTON, Jan. 11, 2012 /PRNewswire/ -- CBI, a division of Advanstar Communications, is pleased to announce the agenda for the 11th Annual Patient Adherence Forum, which is being held April 26 - 27, 2012 at the Loews Hotel in Philadelphia, PA. At the event, industry experts share their strategies for improving patient outcomes and product utilization through stakeholder collaboration and patient engagement. 

Conference highlights include:

  • The 7th Annual Strategic Patient Adherence (SPA) Awards, co-sponsored by CBI and Pharmaceutical Executive. The awards are presented during the conference and give well-deserved recognition for the hard work and dedication of the nominees to improving adherence. Nominations are accepted thru February 3rd. Visit for more information or to apply.
  • A Keynote Presentation from CMS on understanding healthcare reform's greatest impacts on moving the adherence needle.
  • A Keynote Presentation from Weight Watchers for a cross-industry approach to sustainably addressing unhealthy behavior.
  • A Featured Session from D. Stuart Sowder of Pfizer Inc (a 2011 Pharmaceutical Executive Emerging Leader) on utilizing innovative medical communications to educate and motivate patient behavior.

Join us in April for what promises to be a thought-provoking and educational opportunity. To view the entire agenda visit For more information call 800-817-8601. If you would like to apply for a press pass contact Lauren Donoghue:   

Sponsors and Exhibitors include 5th Finger, Adheris, Lash Group and FICO. For more information on sponsorship opportunities contact Lauren Moras:

About CBI:

A subsidiary of Advanstar Communications, CBI offers Pharmaceutical and Healthcare conferences that serve senior executives and government officials by providing a unique platform for highly focused content and ideal networking opportunities with senior policy and decision makers. CBI events provide you with concrete, real-life examples that you can begin to apply at your organization immediately for significant impact on costs and revenue. For more information, please visit

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at

Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. goBalto Completes a Successful FDA 21 CFR Part 11 Compliance Audit
2. MiMedx Group Completes $5,000,000 Private Placement
3. Epitomics, Inc. and University of California, Davis, Complete Star Program for High-Throughput Measurement of Antibody-Antigen Interactions
4. PDL BioPharma Completes Regular Quarterly Dividend Payment
5. CeNeRx BioPharma Completes $4.85 Million Financing
6. Aratana Therapeutics Completes $15 Million Series B Financing
7. InnoPharma Completes $15 Million Series A Financing
8. Biocartis Completes EUR 71 Million (USD 100 Million) Series C Fund Raising
9. Agendia Successfully Completes Bi-Annual FDA Inspection
10. Roche Researchers Sequence Complete Genome of Cynomolgus Monkey and Develop Novel Gene Expression Microarray for Drug Safety Assessment
11. HeartWare Completes GLP Studies of Next Generation MVAD® Pump; Data Presented Today at ISRBP Congress
Post Your Comments:
(Date:6/27/2016)... 2016  Global demand for enzymes is forecast ... to $7.2 billion.  This market includes enzymes used ... biofuel production, animal feed, and other markets) and ... Food and beverages will remain the largest market ... of products containing enzymes in developing regions.  These ...
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created 4Sight ... solutions to the healthcare market. The company's primary focus is on new product ... marketing strategies that are necessary to help companies efficiently bring their products to ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
Breaking Biology Technology:
(Date:6/2/2016)... NEW YORK , June 2, 2016   The ... (Weather), is announcing Watson Ads, an industry-first capability in which ... advertising, by being able to ask questions via voice or ... Marketers have long ... with the consumer, that can be personal, relevant and valuable; ...
(Date:6/1/2016)... YORK , June 1, 2016 ... Technology in Election Administration and Criminal Identification to Boost ... to a recently released TechSci Research report, " Global ... By Region, Competition Forecast and Opportunities, 2011 - 2021", ... 24.8 billion by 2021, on account of growing security ...
(Date:5/20/2016)... , May 20, 2016  VoiceIt is excited ... with VoicePass. By working together, VoiceIt ...  Because VoiceIt and VoicePass take slightly different approaches ... increases both security and usability. ... about this new partnership. "This marketing ...
Breaking Biology News(10 mins):